In order to function properly, the brain must be wired correctly during critical periods in early development. Mistakes in this process are hypothesized to occur in disorders like autism and schizophrenia. Later in life, signaling pathways are essential in maintaining proper communication between neuronal and non-neuronal cells, and disrupting this balance may result in disorders like Alzheimer's disease. The Wnt/b-catenin pathway has a well-established role in cancer. Here, we review recent evidence showing the involvement of Wnt/b-catenin signaling in neurodevelopment as well as in neurodegenerative diseases. We suggest that the onset/development of such pathological conditions may involve the additive effect of genetic variation within Wnt signaling components and of molecules that modulate the activity of this signaling cascade.
Introduction
The beauty of the post-genomic era comes from the realization that natural genetic variation contains much of the information needed to understand key biological phenomena related to differences either in developmental or aging processes. Advances in the past decade have made available large collections of natural genetic variation, with nearly 10 million single nucleotide polymorphisms (SNPs) being expected to occur in the human genome at a frequency X1% and representing 90% of the variation in the human population (Chakravarti, 2001 ; Kruglyak and Nickerson, 2001) . Nonetheless, beauty comes with a price and now it is time to determine the extent of how such genetic variation influences biological processes including disease susceptibility.
Wnt signaling and autism
Autism is a complex neurological disorder characterized by a high degree of impairment in behavioral domains including social interaction, verbal and non-verbal communication and imaginative play (reviewed by Folstein and Rosen-Sheidley (2001) , Hu-Lince et al. (2005) ). Neuroanatomical observations, along with data from functional magnetic resonance imaging, have shown that a major pathological hallmark in autistic individuals may be a premature brain overgrowth affecting structures such as the cerebral cortex, the limbic system, including the hippocampal formation and the amygdala, and the cerebellum (Courchesne et al., 2001 (Courchesne et al., , 2003 Sparks et al., 2002; Schumann et al., 2004) . Such overgrowth would happen early before clinical diagnosis is made consistent with the possibility that growth factors, which normally regulate cell differentiation, proliferation and survival, having a functional role in the disease.
It is well established that Wnt signaling is essential for normal embryonic development of the central nervous system (reviewed by Wilson and Houart (2004) , Ciani and Salinas (2005) ). Indeed, mounting evidence gathered from functional studies of either Wnt ligands or their downstream signaling components, including the complex of receptors, have shown that in the developing brain Wnt signaling participates in patterning the midbrain-hindbrain boundary, which later on gives rise to the brainstem and the cerebellum ( McMahon and Bradley, 1990 ; Thomas and Capecchi, 1990; Thomas et al., 1991; McMahon et al., 1992; Hall et al., 2000) , and forebrain derivatives such as the cerebral cortex, hippocampal formation and the amygdala (Grove et al., 1998; Lako et al., 1998; Lee et al., 2000; Houart et al., 2002; Maretto et al., 2003; Abu-Khalil et al., 2004; Zhou et al., 2004) . Remarkably, embryonic transgenic mice expressing active stabilized forms of b-catenin in neuronal precursor cells developed gross enlargements of the cerebral cortex, hippocampus and amygdala Walsh, 2002, 2003) . All together these studies suggest that Wnt signaling may be a candidate for understanding the abnormal overgrowth and processes underlying complex behaviors occurring very early during the development of an autistic brain. Support for a role of Wnt signaling in autism comes from diverse lines of research, which are briefly outlined below.
First, recent epidemiological studies have shown that in utero exposure to teratogens -agents causing malformations of an embryo or fetus -such as valproic acid (valproate; VPA) causes higher incidence of autism in the offspring (Christianson et al., 1994; Williams and Hersh, 1997; Moore et al., 2000; Folstein and RosenSheidley, 2001; Williams et al., 2001 ). Subsequently, morphological abnormalities similar to those found in autistic individuals have been reported in animals exposed to valproic acid prenatally (Rodier et al., 1997; Ingram et al., 2000; Miyazaki et al., 2005) . Interestingly, valproic acid has been shown to activate Wnt-dependent gene expression by a complex mechanism involving inhibition of GSK3b and histone deacetylase (HDAC) activities (Chen et al., 1999; Phiel et al., 2001; Hall et al., 2002; Bug et al., 2005) . Therefore, valproic acid can activate Wnt signaling and thus Wnt signaling may in part explain the teratogenic effect of the drug.
Second, the co-occurrence of autism and tuberous sclerosis complex (TSC) has been recognized for decades (reviewed by Mak and Yeung (2004) , Wiznitzer (2004) ). Indeed, while the prevalence of TSC in the autistic population is 1-4%, autistic features are present in 25-50% of individuals with TSC. TSC is an autosomal dominant disorder characterized by benign tumors or hamartomas growing in the brain and on other vital organs such as the kidneys, heart, eyes, lungs and skin, and which is caused by defects/mutations on two genes: TSC1 (hamartin in chromosome 9) and TSC2 (tuberin in chromosome 16) (reviewed by Wiznitzer (2004) ). Remarkably, TSC1 and TSC2 form a functional complex with components of the b-catenin degradation machinery, including GSK3b and axin, which negatively regulate b-catenin stability (Mak et al., 2003) and its activation of Wnt target genes (Mak et al., 2005) . Intriguingly, loss of function of either TSC1 or TSC2 trigger an enlargement of somas and dendritic spines and alter the properties of functional synapses in postmitotic hippocampal neurons (Tavazoie et al., 2005) . It remains to be studied whether neuronal deregulation of TSC1/2 augment b-catenin signaling activity thus affecting neuronal plasticity, a phenomenon which is increasingly recognized to be dependent, at least in part, on the normal activity of Wnt signaling components (Salinas, 1999 (Salinas, , 2005 Packard et al., 2002; Wang et al., 2003; Chen et al., 2006) . Third, twin and family studies have provided compelling evidence for a strong genetic component among autistic individuals (Folstein et al., 2003; Hu-Lince et al., 2005; Vorstman et al., 2006) . Multiple genome-wide screens have found evidence for linkage to autism in several chromosomes, including chromosomes 2, 6, 7, 15, 17, 20 and X (International Molecular Genetic Study of Autism Consortium (IMGSAC), 1998, 2001); Barrett et al., 1999; Philippe et al., 1999; Risch et al., 1999; Collaborative Linkage Study of Autism, 2001; Buxbaum et al., 2001; Ylisaukko-oja et al., 2004; Hu-Lince et al., 2005) . Likewise, analysis of reported cytogenetic abnormalities (i.e. deletions, duplications or translocations) related to the autistic phenotype has suggested various chromosomal regions overlapping known loci of significant linkage, supporting the proposed polygenic/ multilocus etiology of autism (Folstein and RosenSheidley, 2001; Vorstman et al., 2006) . Currently, few studies on candidate genes which converge on linkage signals have been consistently associated with autism (Folstein and Rosen-Sheidley, 2001; Bartlett et al., 2005) . Among them, and within a widely confirmed linkage region in the long arm of chromosome 7, recent evidence has shown that Wnt2 and Engrailed 2 (EN2), a Wnt/b-catenin target gene (McGrew et al., 1999) , may be genetically associated with autism (Petit et al., 1995; Wassink et al., 2001; McCoy et al., 2002; Zhong et al., 2003; Gharani et al., 2004; Benayed et al., 2005) .
Indeed, while screening for coding sequence mutations within the Wnt2 gene in autistic probands ascertained through the Collaborative Linkage Study of Autism, Wassink and colleagues found that two families contained non-conservative variants that segregated with the autistic phenotype (Wassink et al., 2001) . Moreover, the authors reported that a SNP in the 3 0 untranslated region (UTR) of the Wnt2 gene was in linkage disequilibrium with a subsample of affectedsibling pair families defined by the presence of severe language abnormalities (Wassink et al., 2001) . Nevertheless, this finding which suggest that mutations in the Wnt2 gene or a more common Wnt2 allele may increase the susceptibility to develop autism, has not been replicated in follow-up studies (McCoy et al., 2002; Li et al., 2004) probably due to small sample size, different allele frequencies for the 3 0 UTR SNP and/or classification of language impairment subgroups between the data sets, and therefore needs further validation.
Finally, a stronger case for the genetic association of the homeobox EN2 gene has been set forward. At present, several polymorphisms in exons as well as introns and regulatory regions of the EN2 gene have been genotyped in different autistic samples including families coming from the Autism Genetic Resource Exchange (AGRE) initiative as well as to the NIMH Center for Collaborative Genetic Studies (Petit et al., 1995; Zhong et al., 2003; Gharani et al., 2004; Benayed et al., 2005) . Previous studies found an association of a PvuII restriction fragment length polymorphism located in the 5 0 UTR region of EN2 in 100 autistic children and 100 control children (Petit et al., 1995) . More recently, in a large number of nuclear families it was demonstrated that two intronic SNPs (SNP id: rs1861972 and rs1861973) were highly associated with the autistic phenotype, both in single locus tests as well as in haplotype analysis (Gharani et al., 2004; Benayed et al., 2005) . Homozygous null mutants for En-2 in mouse display abnormal foliation patterns in the posterior half of the cerebellum and changes in Purkinje and granule cells in some posterior folia (Joyner et al., 1991; Millen et al., 1994; Vogel et al., 1996) . Strikingly, ectopic expression of En-2 in cerebellar Purkinje cells causes restricted cell loss and retarded external germinal layer development (Baader et al., 1998) , a phenotype resembling the cerebellar anatomical abnormalities observed in autistic individuals (Ritvo et al., 1986; Courchesne et al., 2001; Fatemi et al., 2002; Courchesne et al., 2004) . Therefore, the genetic association of the EN2 gene provides the strongest evidence thus far that a Wnt/b-catenin target gene might act as an autism susceptibility locus. Detailed functional studies are needed to determine whether EN2 alleles have differential roles in cerebellar development during pre-or post-natal development.
Schizophrenia and polymorphisms in Frizzled 3 and GSK3b
The neurodevelopmental model of schizophrenia, which is a severe brain disorder with poorly defined etiology and pathophysiology, suggests that interactions between genetic and environmental events occurring during critical early periods of brain development may negatively influence neuronal growth, lamination and orientation resulting in cytoarchitectural defects (reviewed by Rapoport et al. (2005) ). Currently, several reports suggest that the localization or levels of Wnt signaling components are altered in the cortex, subiculum and hippocampus -particularly in CA3 and CA4 regions of the pyramidal cell layer -in schizophrenic patients compared to unaffected individuals. Indeed, Wnt-1 immunoreactivity (Miyaoka et al., 1999) , as well as intraneuronal staining of b-catenin and g-catenin (Cotter et al., 1998) , is altered in post-mortem brains of schizophrenic subjects, suggesting an altered plasticity in a large proportion of schizophrenic brains. More recently, gene expression analysis of the Wnt signaling antagonist Dickkopf-3 (Dkk3) has shown that its transcript is downregulated in cortical neurons of schizophrenic brains (Ftouh et al., 2005) .
Frizzled-3 (FZD3) is an almost ubiquitous transmembrane receptor for secreted Wnt ligands involved in the specification of several structures, including neural crest derivatives and the development of major fiber tracts in the central nervous system (Sala et al., 2000; Wang et al., 2002) . The human FZD3 gene is located on chromosome 8p21, a linkage locus containing a putative gene for schizophrenia (Pulver et al., 1995; Blouin et al., 1998; Kendler et al., 2000; Gurling et al., 2001) . Candidate gene association studies in this region have shown that SNPs within the FZD3 gene are strongly associated with schizophrenia in Chinese Han (Yang et al., 2003; Zhang et al., 2004) , as well as in Japanese descents (Katsu et al., 2003) . Nevertheless, such findings remain controversial since other groups have not been able to replicate and extend these observations in other populations (Ide et al., 2004; Jeong et al., 2006) . The strong association between the FZD3 locus and schizophrenia is suggestive that the gene itself may play a role in underlying schizophrenia, but until functional data become available, a nearby gene in linkage disequilibrium with FZD3 responsible for predisposing to the illness cannot be excluded.
If Wnt signaling underlies cytoskeletal abnormalities during the onset or progression of neurodevelopmental disorders it is expected that pharmacological intervention of the signaling cascade by way of modulating the activity of its signaling components may have a functional effect on the progression of such disorders. In this context, GSK-3b is regarded as playing a major role in the pathogenesis of various neurological disorders including schizophrenia (see also below). Indeed, several reports have shown that GSK-3b levels or its phosphorylation state (Ser-9-GSK3b), are altered among schizophrenic individuals (Kozlovsky et al., 2000 (Kozlovsky et al., , 2001 Beasley et al., 2001; Emamian et al., 2004) . Moreover, GSK-3b has been shown to be a target of the action mood-stabilizers such as lithium and VPA ( Klein and Melton, 1996; Chen et al., 1999; Hall et al., 2002) , antipsychotics drugs, as clozapine, haloperidol and risperidone (Alimohamad et al., 2005a, b) and psychotomimetics drugs, which induce an schizophreniclike state in humans and animal models (Svenningsson et al., 2003; Ahn et al., 2005) .
Despite the widely accepted view that schizophrenia and bipolar disorder represent independent illnesses and modes of inheritance, some data in the literature suggest that the diseases may share some genetic susceptibility (Bailer et al., 2002) . One such region is mapped to the long arm of chromosome 3 (Bailer et al., 2002) in the vicinity of the GSK-3b gene (3q13.3) (Shaw et al., 1998) . In this regard, recent evidence suggests that a (CAA)(n) repeat polymorphism localized in intron 1 of GSK3b could be genetically associated with a subtype of schizophrenic patients (Scassellati et al., 2004) . Likewise, the GSK3b -50T/C SNP, which falls into the effective promoter region (nt À171 to þ 29) of the gene (Shaw et al., 1998) has been linked with age at onset (Benedetti et al., 2004a, b) and with the therapeutic longterm response to lithium salts in individuals affected by bipolar illness (Benedetti et al., 2005) . GSK3b is abundantly expressed in the developing and the adult brain of mammals, being confined to neuronal cells ( Leroy and Brion, 1999) . Interestingly, the expression of GSK3b varies considerably between cells and tissues and thus may be subject to a strong regulation (Lau et al., 1999; Leroy and Brion, 1999) , which may be driven by the temporal availability of regulatory elements. Therefore, it remains as an exciting challenge to determine whether common genetic variation, as seen above, is responsible for differential regulation of the GSK3b enzyme.
Alzheimer's disease, Apolipoprotein E and Wnt signaling
Alzheimer's disease (AD) -the most common form of age-related dementia -is a progressive neurodegenerative disorder characterized by a deficit in cognitive processes that are manifested as alterations in memory, judgment and reasoning (reviewed in Hardy and Selkoe, 2002) . To date, several studies have shown that the Wnt signaling components b-catenin and GSK3b form multiprotein complexes with the early-onset familial AD-linked presenilin proteins (Zhou et al., 1997; Takashima et al., 1998b; Kang et al., 2002) . b-Catenin levels are significantly reduced in AD individuals bearing presenilin mutations (Zhang et al., 1998) and active GSK3b accumulates in vivo in AD brains (Pei et al., 1999) , where it has a key role in the hyperphosphorylation of the microtubule-associated protein tau (Hanger et al., 1992; Lovestone et al., 1994; Lucas et al., 2001; Sato et al., 2002; Li et al., 2006) . Moreover, Wnt signaling may also have an essential role in the processing of the amyloid precursor protein (Mudher et al., 2001; Sun et al., 2002; Phiel et al., 2003) , as well as in the neurotoxicity of its derivative the amyloid b-peptide (Ab) (Takashima et al., 1998a; Alvarez et al., 2002; De Ferrari et al., 2003; Alvarez et al., 2004; Caricasole et al., 2004) . Remarkably, it has been reported that Ab neurotoxicity induces the expression of Dickkopf 1 (Dkk1) (Caricasole et al., 2004) , which may further antagonize Wnt presentation to its complex receptor. All together the data indicate that the activity of Wnt signaling components is compromised in AD brains and thus underlies Ab generation/toxicity/deposition and tau hyperphosphorylation, major pathological hallmarks of this neurodegenerative condition (De Ferrari and Inestrosa, 2000; Mudher and Lovestone, 2002; Caricasole et al., 2003; Moon et al., 2004) .
Although the etiology of AD remains to be fully understood, it is well accepted that along with age, family history is the most prominent risk factor for the development of the disease. Currently, variation at the apolipoprotein E (APOE) locus on chromosome 19 plays a role in more cases of AD than does any other genetic determinant. Inheritance of the APOE-e4 allele is a risk factor for AD, including both the sporadic and late-onset familial forms of the disease (Corder et al., 1993; Saunders et al., 1993; Strittmatter et al., 1993) . APOE is a component of several classes of secreted lipoproteins that mediate ligand-receptor presentation/ endocytosis through the low-density lipoprotein receptor (LDLR) family of single transmembrane proteins (reviewed by Herz (2001) , Li et al. (2001) ). Potentially overlapping functions attributed to APOE include lipid transport, maintenance of neuroplasticity, and the modulation of the activities of the major hallmarks of AD brains: Ab deposition/neurotoxicity and the hyperphosphorylation state of tau (reviewed by Rebeck et al., 2002 , Teter et al., 2002 ).
It has been suggested that the correlation between the isoform-specific effect of APOE-e4 allele and AD may relate to defective clearance of Ab through the members of the LDLR family, most notably the LDLR-related protein-1 (LRP1). Nonetheless, LRP1 levels decline normally in the aging population and are drastically reduced in AD brains (Kang et al., 2000) , suggesting that once LRP1 is absent other receptors might become important in modulating the effects of APOE. In recent years it has become clear that the highly homologous LRP5 LRP6 (Brown et al., 1998) proteins are crucial for reception of the Wnt signal transduction pathway (Pinson et al., 2000; Tamai et al., 2000; Wehrli et al., 2000) . Although we lack conclusive evidence regarding the interaction between LRP5/6 and APOE at the cellular and molecular levels, it has been proposed that LRP5/6 may recognize and be involved in APOE catabolism (Kim et al., 1998; Magoori et al., 2003) . Moreover, recent experiments suggest that apolipophorins, the ortholog for APOE proteins in Drosophila, copurify and act as vehicles for the movement of lipid-linked morphogens including the Wnt ortholog Wingless (Panakova et al., 2005) . Thus, it is likely that APOE has a conserved role during evolution and may recognize and regulate the function of Wnt ligands by helping in their presentation to its complex receptor which includes the LRP5/6 proteins. Then, further studies are needed to understand whether Wnt signaling function can be modulated by either APOE isoforms (i.e. APOE-e2, APOE-e3 and APOE-e4) or APOE-Ab complexes, as is observed in AD brains.
Finally, epidemiological studies estimate that a great proportion of AD sufferers (B50%) do not present the APOE-e4 allele, suggesting that additional genetic or environmental factors could play essential roles in the disease (Warwick Daw et al., 2000) . A fact consistent with this observation is that genome-wide screens have identified several regions that show significant linkage to AD, of which the most likely to harbor new risk factors are chromosomes 1, 9, 10, 12, 19 and 21 (Pericak-Vance et al., 1997; Rogaeva et al., 1998; Wu et al., 1998; Kehoe et al., 1999; Scott et al., 2000; Mayeux et al., 2002; Myers et al., 2002; Blacker et al., 2003; Saunders et al., 2003) . Several candidate gene association studies have recently focused in examining common genetic variation among Wnt signaling components in AD. These studies have included analyses of GSK3b gene in chromosome 3 (Russ et al., 2001; Mateo et al., 2006) , Disheveled 1 in chromosome 1 (Russ et al., 2002) and a-T-catenin in the long arm of chromosome 10 (Ertekin- Taner et al., 2003; Blomqvist et al., 2004; Busby et al., 2004) . Nevertheless, it is not clear whether those genes may represent risk for AD and thus several other chromosomal regions are currently being explored. In this regard, analysis of the reported linkage region in chromosome 12 reveals that there are two peaks, one of them clustering towards the p-ter arm in the vicinity of the Wnt coreceptor LRP6 gene. Interestingly, it has been recently reported that a highly conserved coding sequence LRP6 polymorphism (SNP id. rs2302685; Ile1062-Val) was associated with increased fracture risk in men (van Meurs et al., 2006) . Moreover, it was found a synergistic effect between the LRP6 (Ile1062-Val) variant and a similar coding sequence SNP in the LRP5 gene (SNP id. rs3736228; Ala1330-Val), which increased the risk and accounting for B10% of the fractures in males (van Meurs et al., 2006) . Likewise, common LRP6 variants showed evidence both for linkage and association with agerelated macular degeneration (Haines et al., 2006) . Therefore, given that both conditions are frequent in the elderly and may share common pathological mechanisms with AD (Malek et al., 2005) , it is possible that these genetic variants may also have a role in determining susceptibility to develop AD. Further studies are needed to determine whether such variants display differential Wnt signaling activity.
Conclusion
As outlined in this review, prevalent neurological disorders with a complex mode of inheritance like autism, schizophrenia and AD are thought to arise due to multiple gene-gene as well as gene-environment interactions. Here, we aimed at gathering scattered observations regarding the participation of Wnt signaling components -or molecules that modulate their activity -as a framework for understanding the onset or development of such pathological conditions. As a result, an emerging picture can be drawn where deregulation of the Wnt/b-catenin signaling pathwaybut acting in opposite directions: Ups and Downsmight help to explain both neurodevelopmental and neurodegenerative conditions.
